查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2010029

磁振造影（MRI）市場：2026-2032年全球市場預測（依產品類型、磁場強度、磁鐵類型、線圈類型、應用和最終用戶分類）

Magnetic Resonance Imaging Market by Product Type, Field Strength, Magnet Type, Coil Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年 MRI（磁振造影）市值為 64.8 億美元，預計到 2026 年將成長至 68.3 億美元，複合年成長率為 5.91%，到 2032 年將達到 96.9 億美元。

主要市場統計數據
基準年 2025 64.8億美元
預計年份：2026年 68.3億美元
預測年份 2032 96.9億美元
複合年成長率 (%) 5.91%

權威的介紹，將 MRI 定位為一種綜合的臨床技術和服務模式，它塑造了採購、工作流程和以患者為中心的護理。

磁振造影（MRI）持續處於臨床創新和醫療系統轉型的交會點，在提供無與倫比的診斷準確性的同時，還能適應不斷變化的營運限制。此次實施將MRI定位為技術平台和服務模式，突顯了硬體、軟體和護理模式的進步如何整合並影響採購、利用和患者的治療路徑。

磁振造影技術的融合、人工智慧主導的診斷影像技術的進步、不斷發展的服務模式以及監管期望正在如何重塑 MRI 的臨床和商業性路徑。

磁振造影（MRI）領域正經歷一場變革，這主要得益於磁體設計、影像重建演算法以及臨床工作流程整合的同步進步。高效能掃描器和不斷發展的低場架構正在重新定義影像解析度、成本和可及性之間的權衡。同時，人工智慧驅動的重建和自動化技術正在催生新的掃描方案，這些通訊協定能夠縮短掃描時間，減少對高度專業化操作人員的依賴，並擴大其在各類患者群體中的臨床效用。

本研究評估了 2025 年關稅措施如何透過供應鏈重組和採購模式轉型，重塑了 MRI 採購、供應商策略和臨床准入。

2025年推出的政策環境對整個醫療保健系統的磁振造影（MRI）供應鏈、籌資策略和成本結構產生了重大影響。進口零件和成品系統的關稅調整改變了供應商之間的相對競爭力，促使採購團隊重新評估總體擁有成本並對供應商的供貨承諾進行壓力測試。因此，籌資策略正轉向近岸外包、多供應商合約和策略性庫存緩衝相結合的方式，以降低交付的不確定性。

將產品、磁場強度、磁鐵和線圈配置、應用和最終用戶趨勢與技術採用的促進因素聯繫起來的全面細分洞察。

細分市場為理解整個磁振造影（MRI）生態系統中的技術選擇、臨床工作流程和採購行為提供了一個分析觀點。根據產品類型，採購決策可分為封閉式MRI系統和開放式MRI系統。封閉式MRI系統優先考慮高場強和廣泛的臨床適用性，而開放式MRI系統則優先考慮患者體驗、特定介入目標患者以及恐懼症患者。這些產品差異會影響資金分配、設施規劃和通訊協定製定。

區域 MRI 分析揭示了每個地區的基礎設施、報銷制度和醫療服務提供者的特徵如何影響其採用軌跡和商業策略。

區域環境影響著磁振造影（MRI）的普及模式、報銷結構、監管路徑和基礎設施建設進展。在美洲，資本市場、支付方結構以及緊密的私人醫療服務提供者網路加速了高場系統和捆綁式服務模式的普及，同時也支撐著蓬勃發展的售後市場生態系統。這些趨勢凸顯了健全的服務網路和價值論證在證明高價設備應用合理性的重要性。

關鍵的企業級洞察，展示了產品差異化、售後市場卓越性、策略夥伴關係和靈活的商業模式如何創造永續的競爭優勢。

磁振造影（MRI）生態系統中的關鍵參與者正透過結合技術創新、卓越的售後服務和策略夥伴關係關係來實現差異化競爭。一些供應商將研發重點放在演算法影像校正和工作流程自動化上，以提高吞吐量並降低每次檢查的成本。而另一些供應商則優先考慮硬體差異化，透過磁鐵和線圈的創新來擴展臨床應用。這些不同的策略凸顯了產品投資與已確定的臨床未滿足需求和最終用戶偏好相符的重要性。

為原始設備製造商、供應商和分銷商提供具體的策略建議，以加強產品藍圖、服務模式、供應鏈和支付方參與，從而實現永續成長。

產業領導企業應優先採取一系列策略行動，以最大限度地提高臨床影響力和商業性韌性，同時應對技術、監管和市場壓力。首先，應投資於平台模組化和升級路徑，以縮短更換週期，並允許客戶逐步擴展其功能。這種方法可以降低客戶獲取門檻，並使供應商的獎勵與提供長期臨床價值保持一致。

採用透明的混合方法調查方法，結合專家對話、第二手資料整合和分析框架，以檢驗對 MRI 市場的洞察。

本研究採用混合方法研究策略，旨在確保研究結果的透明度、可重複性和對決策者的相關性。該調查方法結合了與臨床和商業專家的結構化對話、對監管和政策文件的二次分析，以及對技術文獻的系統性回顧，以闡明技術進步和應用模式的背景。這些要素經過交叉檢驗，以檢驗結果並減少偏差。

一項將技術進步、政策影響、市場區隔現實和區域差異相結合的權威、綜合分析，指導了策略性 MRI 投資和專案設計。

這份總結性的綜合分析協調了技術趨勢、政策轉變、市場區隔動態和區域背景，從而對磁振造影（MRI）的短期發展軌跡提供了一致的觀點。技術進步——特別是影像重建、模組化硬體和線圈方面的創新——正在拓展臨床應用，同時也降低了部分准入門檻。同時，政策措施和供應鏈重組正在加速採用靈活的部署和服務模式，從而降低醫療服務提供者的資本投資風險。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：磁振造影（MRI）市場：依產品類型分類

  • 封閉式磁振造影
  • 開放式磁振造影

第9章：磁振造影（MRI）市場依磁場強度分類

  • 高磁場
  • 低磁場
  • 超高磁場

第10章：磁振造影（MRI）市場以磁體類型分類

  • 永久磁鐵
  • 電阻類型
  • 超導性

第11章：以線圈類型分類的磁振造影（MRI）市場

  • 體內線圈
  • 心臟線圈
  • 肢體線圈
  • 頭部線圈

第12章磁振造影（MRI）市場：依應用領域分類

  • 循環系統
  • 肌肉骨骼系統
  • 神經病學
    • 腦部影像診斷
    • 脊髓成像
  • 腫瘤學
    • 血液癌症影像診斷
    • 固態腫瘤影像

第13章磁振造影（MRI）市場：依最終用戶分類

  • 學術研究機構
  • 診斷影像中心
  • 醫院
    • 私立醫院
    • 公立醫院

第14章磁振造影（MRI）市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章磁振造影（MRI）市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章磁振造影（MRI）市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國磁振造影（MRI）市場

第18章：中國磁振造影（MRI）市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Analogic Corporation
  • Aspect Imaging Ltd.
  • Aurora Imaging Technology, Inc.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Esaote SpA
  • Fonar Corporation
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • IMRIS/Deerfield Imaging, Inc.
  • Koninklijke Philips NV
  • MR Solutions Group Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Time Medical Limited
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-434CCDA04EB2

The Magnetic Resonance Imaging Market was valued at USD 6.48 billion in 2025 and is projected to grow to USD 6.83 billion in 2026, with a CAGR of 5.91%, reaching USD 9.69 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.48 billion
Estimated Year [2026] USD 6.83 billion
Forecast Year [2032] USD 9.69 billion
CAGR (%) 5.91%

An authoritative introduction framing MRI as a convergent clinical technology and service paradigm that shapes procurement, workflows, and patient-centric care

Magnetic resonance imaging continues to stand at the intersection of clinical innovation and healthcare systems transformation, delivering unparalleled diagnostic clarity while adapting to evolving operational constraints. This introduction frames MRI as both a technology platform and a service paradigm, where advances in hardware, software, and care models converge to influence procurement, utilization, and patient pathways.

Over recent years, image quality improvements have been accompanied by growing expectations for throughput, accessibility, and cost-effectiveness. Consequently, stakeholders across the imaging ecosystem are recalibrating priorities: vendors are balancing R&D investments between high-field performance and low-cost accessibility, while providers are integrating MRI into multidisciplinary care protocols and value-based delivery models. Transitioning from episodic capital acquisition to lifecycle-oriented service agreements and outcome-focused delivery has become a critical strategic consideration.

Moving forward, MRI's strategic value will be judged by its ability to deliver diagnostic confidence, interoperability within diagnostic chains, and demonstrable contributions to patient outcomes. This introduction sets the stage for an in-depth examination of technological shifts, policy impacts, segmentation-driven dynamics, regional variations, competitive positioning, and practical recommendations that follow.

How converging magnet technologies, AI-driven imaging advances, evolving service models, and regulatory expectations are reshaping MRI clinical and commercial pathways

The MRI landscape is undergoing transformative shifts driven by simultaneous advances in magnet design, image reconstruction algorithms, and clinical workflow integration. High-performance scanners and evolving low-field architectures are reshaping the trade-offs between image resolution, cost, and accessibility. At the same time, AI-enabled reconstruction and automation are accelerating scan times, reducing dependence on highly specialized operators, and enabling new protocols that expand clinical utility across patient cohorts.

In parallel, the aftermarket and service models are evolving: service contracts increasingly emphasize uptime guarantees, predictive maintenance, and remote diagnostics to protect clinical continuity. Supply-chain diversification and modular hardware architectures are reducing lead times and enabling incremental upgrades rather than full replacements. These developments are prompting providers to adopt mixed-portfolio strategies, combining flagship systems for complex diagnostics with more agile platforms for routine imaging.

Regulatory frameworks and payer expectations are also shifting, with a growing emphasis on evidence of clinical effectiveness and cost utility. Consequently, stakeholders must integrate clinical validation, interoperability, and value demonstration into their commercialization and deployment strategies. Taken together, these shifts are redefining how MRI is procured, deployed, and monetized across healthcare systems.

Evaluating how 2025 tariff measures have reshaped MRI procurement, supplier strategies, and clinical access through supply-chain reconfiguration and acquisition model shifts

The policy environment introduced in 2025 has imparted material effects on MRI supply chains, procurement strategies, and cost structures across healthcare delivery systems. Tariff adjustments on imported components and finished systems have altered relative supplier competitiveness, prompting procurement teams to reevaluate total cost of ownership and to stress-test vendor supply commitments. As a result, sourcing strategies have shifted toward a combination of nearshoring, multi-vendor agreements, and strategic inventory buffering to mitigate delivery uncertainty.

These changes have consequences beyond procurement. Capital approval cycles now incorporate scenario planning for tariff-induced price volatility and potential delays in equipment deployment. Hospital finance teams and imaging centers are increasingly favoring flexible acquisition models-such as modular upgrades and service-based arrangements-that decouple clinical capacity expansion from large upfront expenditures. Simultaneously, some vendors are accelerating localization of manufacturing and establishing regional parts depots to safeguard service continuity.

Clinically, the cumulative impact has encouraged providers to optimize utilization through scheduling efficiencies and protocol standardization, thereby preserving diagnostic access amid equipment constraints. In summary, the 2025 tariff environment has accelerated structural changes in how MRI systems are sourced, serviced, and integrated into clinical delivery models.

Comprehensive segmentation insights that connect product, field strength, magnet and coil configurations, applications, and end-user dynamics to technology adoption drivers

Segmentation provides the analytical lens for understanding technology selection, clinical workflows, and purchasing behavior across the MRI ecosystem. Based on Product Type, purchasing decisions differentiate between Closed MRI systems, favored for high-field performance and broad clinical applicability, and Open MRI systems, which prioritize patient experience and certain interventional or claustrophobic patient cohorts. These product distinctions influence capital allocation, site planning, and protocol development.

Based on Field Strength, clinical programs stratify needs among High Field systems that support advanced neuro and oncologic protocols, Low Field systems that balance affordability with improved accessibility, and Ultra-High Field systems that enable cutting-edge research and specialized diagnostics. Choices in field strength intersect closely with magnet architecture. Based on Magnet Type, Permanent magnets are valued for low operating overhead in constrained settings, Resistive magnets offer specific niche advantages, and Superconducting magnets continue to dominate high-resolution clinical imaging and research environments.

Based on Coil Type, clinical utility is further refined by the availability of Body Coil, Cardiac Coil, Extremity Coil, and Head Coil options, which determine protocol specificity and multi-organ versatility. Based on Application, MRI service design must accommodate Cardiovascular, Musculoskeletal, Neurology - including Brain Imaging and Spinal Cord Imaging - and Oncology - including Hematological Cancer Imaging and Solid Tumor Imaging - each with distinct imaging requirements and throughput considerations. Finally, based on End User, deployment decisions reflect the needs of Academic And Research Institutes, Diagnostic Imaging Centers, and Hospitals, with hospital segment dynamics differentiating Private Hospitals and Public Hospitals in procurement priorities, funding models, and adoption timelines. Together, these segmentation dimensions illuminate where investment, training, and product innovation will deliver the greatest clinical and commercial return.

Regional MRI insights that delineate how infrastructure, reimbursement, and provider archetypes in each global region shape adoption trajectories and commercial strategies

Regional context drives adoption patterns, reimbursement structures, regulatory pathways, and infrastructure readiness for MRI deployment. In the Americas, capital markets, payer structures, and a dense network of private providers often accelerate adoption of higher-field systems and bundled service models, while also supporting vigorous aftermarket ecosystems. These dynamics emphasize the importance of robust service networks and value demonstration to justify premium equipment.

Across Europe, Middle East & Africa, heterogeneity in regulatory regimes and healthcare financing shapes divergent adoption curves. In many markets, constrained capital allocation and centralized procurement encourage the adoption of cost-effective platforms and shared-service models, whereas leading academic centers continue to invest in ultra-high-field systems tied to research excellence. Infrastructure variability also increases the importance of modular and low-maintenance designs in several regions within this cluster.

The Asia-Pacific region exhibits rapid expansion in diagnostic capacity driven by growing investment in healthcare infrastructure, demographic trends, and policy initiatives to broaden access. This environment favors scalable solutions that combine affordability with upgrade pathways and strong local service models. Taken together, regional distinctions require tailored commercial strategies that align product positioning with reimbursement realities, local clinical priorities, and supply-chain ecosystems.

Key company-level insights showcasing how product differentiation, aftermarket excellence, strategic partnerships, and flexible commercial models create sustainable competitive advantage

Leading participants within the MRI ecosystem are differentiating through a combination of technological innovation, aftermarket excellence, and strategic partnerships. Some vendors concentrate R&D on algorithmic image enhancement and workflow automation to improve throughput and lower per-study costs, while others prioritize hardware differentiation through magnet and coil innovations that expand clinical capability. These divergent approaches underscore the importance of aligning product investments with identified clinical unmet needs and end-user preferences.

Service and support capabilities have emerged as competitive differentiators. Organizations that offer predictive maintenance, rapid parts provisioning, and outcome-oriented service agreements strengthen customer retention and reduce operational risk for providers. Meanwhile, alliances between vendors, software providers, and clinical networks create ecosystems that streamline deployment of new protocols and facilitate multicenter evidence generation. Investment in training and clinical support further reinforces adoption by reducing the time to clinical utility.

Finally, growth strategies increasingly rely on flexible commercial models-rental, pay-per-scan, or managed equipment services-that lower barriers to entry for constrained facilities and enable incremental scaling. Companies that integrate clinical evidence generation, robust service models, and adaptable commercial terms will be best positioned to capture long-term preference in a competitive landscape.

Actionable strategic recommendations for OEMs, providers, and distributors to strengthen product roadmaps, service models, supply chains, and payer engagement for sustained growth

Industry leaders should prioritize a set of strategic actions to navigate technological, regulatory, and market pressures while maximizing clinical impact and commercial resilience. First, invest in platform modularity and upgrade pathways that reduce replacement cycles and enable customers to scale functionality incrementally. Such an approach lowers customer acquisition friction and aligns vendor incentives with long-term clinical value delivery.

Second, expand service propositions beyond traditional maintenance to include predictive analytics, outcome-linked service level agreements, and clinician training programs. These elements not only protect uptime but also embed vendors more deeply into clinical pathways, creating stickiness and defensibility. Third, pursue supply-chain diversification and regional manufacturing or components localization where feasible to reduce exposure to policy-driven cost shocks and to shorten lead times for parts and systems.

Fourth, collaborate with payers and health systems to develop evidence packages that demonstrate diagnostic and care-pathway value, thereby supporting coverage and utilization. Finally, tailor commercial models-such as subscription, managed services, and shared ownership-to align with varied end-user financial constraints. Implementing these recommendations will enable vendors and providers to deliver measurable clinical benefits while buffering against market volatility.

A transparent mixed-methods research methodology integrating expert engagement, secondary evidence synthesis, and analytical frameworks to validate MRI market insights

This study synthesizes insights from a mixed-methods research approach designed to ensure transparency, reproducibility, and relevance to decision-makers. The methodology integrates structured engagements with clinical and commercial experts, secondary analysis of regulatory and policy documents, and systematic review of technology literature to contextualize technological trajectories and adoption patterns. These elements are triangulated to validate findings and to reduce bias.

Primary research involved interviews and workshops with stakeholders across clinical specialties, procurement offices, and senior vendor leadership to capture real-world decision criteria, pain points, and early indicators of technology adoption. Secondary research sources comprised peer-reviewed clinical studies, regulatory filings, and supplier product documentation to corroborate claims related to performance, safety, and intended use. Analytical frameworks applied include lifecycle cost analysis for procurement considerations, clinical pathway mapping to assess service impact, and scenario analysis to evaluate policy and supply-chain contingencies.

Quality assurance measures included cross-verification of interview inputs, internal peer review of analytical outputs, and sensitivity checks on key interpretive conclusions. This methodological rigor underpins the report's actionable conclusions and recommendations for stakeholders seeking to align strategy with evolving MRI ecosystem dynamics.

Conclusive synthesis aligning technological advances, policy impacts, segmentation realities, and regional differences to guide strategic MRI investments and program design

This concluding synthesis reconciles technology trends, policy shifts, segmentation dynamics, and regional contexts to provide a cohesive perspective on MRI's near-term trajectory. Technological advances-particularly in image reconstruction, modular hardware, and coil innovation-are expanding clinical applications while lowering some barriers to access. Concurrently, policy actions and supply-chain reconfiguration have accelerated the adoption of flexible acquisition and service models that de-risk capital investment for providers.

Segmentation analysis clarifies that clinical and commercial choices will continue to vary by field strength, magnet design, coil complement, and end-user funding models, which necessitates tailored value propositions. Regionally, diverse reimbursement and infrastructure realities demand market-entry strategies that are localized and evidence-driven. Competitive differentiation will increasingly hinge on service excellence, interoperability, and demonstrable contributions to clinical pathways.

In sum, successful stakeholders will be those who integrate technical innovation with robust service models, adaptable commercial terms, and proactive engagement with payers and providers. This integrated approach will enable MRI to retain its central role in diagnostic care while evolving to meet changing system-level imperatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnetic Resonance Imaging Market, by Product Type

  • 8.1. Closed MRI
  • 8.2. Open MRI

9. Magnetic Resonance Imaging Market, by Field Strength

  • 9.1. High Field
  • 9.2. Low Field
  • 9.3. Ultra-High Field

10. Magnetic Resonance Imaging Market, by Magnet Type

  • 10.1. Permanent
  • 10.2. Resistive
  • 10.3. Superconducting

11. Magnetic Resonance Imaging Market, by Coil Type

  • 11.1. Body Coil
  • 11.2. Cardiac Coil
  • 11.3. Extremity Coil
  • 11.4. Head Coil

12. Magnetic Resonance Imaging Market, by Application

  • 12.1. Cardiovascular
  • 12.2. Musculoskeletal
  • 12.3. Neurology
    • 12.3.1. Brain Imaging
    • 12.3.2. Spinal Cord Imaging
  • 12.4. Oncology
    • 12.4.1. Hematological Cancer Imaging
    • 12.4.2. Solid Tumor Imaging

13. Magnetic Resonance Imaging Market, by End User

  • 13.1. Academic And Research Institutes
  • 13.2. Diagnostic Imaging Centers
  • 13.3. Hospitals
    • 13.3.1. Private Hospitals
    • 13.3.2. Public Hospitals

14. Magnetic Resonance Imaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Magnetic Resonance Imaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Magnetic Resonance Imaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Magnetic Resonance Imaging Market

18. China Magnetic Resonance Imaging Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agilent Technologies, Inc.
  • 19.6. Analogic Corporation
  • 19.7. Aspect Imaging Ltd.
  • 19.8. Aurora Imaging Technology, Inc.
  • 19.9. Bruker Corporation
  • 19.10. Canon Medical Systems Corporation
  • 19.11. Esaote S.p.A.
  • 19.12. Fonar Corporation
  • 19.13. Fujifilm Holdings Corporation
  • 19.14. GE HealthCare Technologies, Inc.
  • 19.15. Hitachi, Ltd.
  • 19.16. Hologic, Inc.
  • 19.17. IMRIS / Deerfield Imaging, Inc.
  • 19.18. Koninklijke Philips N.V.
  • 19.19. MR Solutions Group Ltd.
  • 19.20. Neusoft Medical Systems Co., Ltd.
  • 19.21. Shimadzu Corporation
  • 19.22. Siemens Healthineers AG
  • 19.23. Time Medical Limited
  • 19.24. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGNETIC RESONANCE IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CLOSED MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CLOSED MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CLOSED MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY OPEN MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY OPEN MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY OPEN MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY LOW FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY LOW FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY LOW FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ULTRA-HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ULTRA-HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ULTRA-HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PERMANENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PERMANENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PERMANENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY RESISTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY RESISTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY RESISTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUPERCONDUCTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUPERCONDUCTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUPERCONDUCTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BODY COIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BODY COIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BODY COIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIAC COIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIAC COIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIAC COIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY EXTREMITY COIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY EXTREMITY COIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY EXTREMITY COIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEAD COIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEAD COIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEAD COIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BRAIN IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BRAIN IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SPINAL CORD IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SPINAL CORD IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEMATOLOGICAL CANCER IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEMATOLOGICAL CANCER IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEMATOLOGICAL CANCER IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SOLID TUMOR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SOLID TUMOR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SOLID TUMOR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 181. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 211. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 221. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)